Skip to content
  • World News
  • Business
  • Aviation
  • Military
  • Energy
  • Lifestyle
  • Real Estate
  • Auto
195News

195News

All the news that's fit to print

  • World News
  • Business
  • Aviation
  • Military
  • Energy
  • Lifestyle
  • Real Estate
  • Auto
  • Toggle search form
  • Togg Turkish Electric SUV Spied Testing In Germany
    Togg Turkish Electric SUV Spied Testing In Germany Aviation
  • adani green energy share latest news ||most valuable companies| adani energy share latest news today
    adani green energy share latest news ||most valuable companies| adani energy share latest news today Energy
  • Global Servo Motors and Drives Market Trends, Strategies, Opportunities For 2022-2031
    Global Servo Motors and Drives Market Trends, Strategies, Opportunities For 2022-2031 Auto
  • IAF Ranks Third After US & Russia On World Air Power Index, Beats China & France | NewsMo
    IAF Ranks Third After US & Russia On World Air Power Index, Beats China & France | NewsMo Aviation
  • Plug-In Car Sales Growth Stalled In May 2022
    Plug-In Car Sales Growth Stalled In May 2022 Aviation
  • In this hot real estate market, should you buy?  l  GMA
    In this hot real estate market, should you buy? l GMA Real Estate
  • Top Gear Likes The Ford F-150 Lightning But Texans Aren’t As Convinced… Aviation
  • Getting an eVTOL off the ground
    Getting an eVTOL off the ground Aviation
C4 Imaging Announces First Prostate Cancer Treatments Utilizing Nova™ Fiducial Markers

C4 Imaging Announces First Prostate Cancer Treatments Utilizing Nova™ Fiducial Markers

Posted on June 8, 2022 By Business - Social Gov
C4 Imaging Announces First Prostate Cancer Treatments Utilizing Nova™ Fiducial Markers

C4 Imaging announces the first prostate cancer cases utilizing the Nova™ marker – designed to maximize MRI utility to improve the accuracy of cancer treatment.

We’re thrilled that Dr. Marcus and Dr. Rossi, renowned leaders in the field of Radiation Oncology chose to utilize Nova™”

— Andrew Bright

HOUSTON, TEXAS, USA, May 31, 2022 /EINPresswire.com/ — C4 Imaging Announces First Prostate Cancer Treatments Utilizing Nova™ Fiducial Markers

C4 Imaging LLC is pleased to announce the first prostate cancer treatments utilizing Nova™, a multimodality fiducial marker designed to maximize MRI utility in improving the accuracy of cancer treatment. The procedures were performed by Dr Peter Rossi and Dr David Marcus, radiation oncologists, at Valley View’s Calaway • Young Cancer Center in Glenwood Springs, Colorado.

“We’re delighted to be first to use Nova Fiducial Markers,” said Peter Rossi MD, who in June assumes the role of President of the American Brachytherapy Society. “Nova’s positive-signal MR image allows us to co-register each patient’s precise MR based anatomy with a corresponding CT image. This increases precision in the planning and delivery of treatment, and really enables us to personalize treatment for each patient.” Dr. Rossi added.

Image guidance utilizing fiducial markers is an important option to reduce margins of uncertainty while planning radiotherapy treatment. This ensures radiation is focused on the cancer, rather than on surrounding healthy anatomy, optimizing cure rates, and minimizing the risk of side effects. Most fiducial markers contain solid metal which can cause imprecise voids, or artifacts, on MR images. Nova Fiducial Markers contains a proprietary, patented combination of non-metallic materials that allows for a positive-signal image.

Radiation Oncologists and their teams often combine MR and CT images, referred to as co-registration or image fusion, to precisely plan where radiotherapy will be targeted. With Nova they are able to co-register MR and CT images without the concern of artifacts, and then utilize Nova’s CT or x-ray imaging properties to precisely align radiation throughout the course of each patient’s treatment.

Andrew Bright, President, and CEO of C4 Imaging, commented, “We’re thrilled that Dr. Marcus and Dr. Rossi, renowned leaders in the field of Radiation Oncology chose to utilize Nova™.” Mr. Bright added, “Both have long recognized the clinical value of MR imaging in managing prostate cancer patients. Their expertise, coupled with The Calaway • Young Cancer Center’s desire to adopt cutting-edge technology affirm the quality of care that’s delivered at this regional center of excellence.”

About C4 IMAGING

C4 Imaging develops medical devices that enable clinicians to perform image-guided procedures more accurately. The company’s proprietary technology, C4, has been developed as Sirius®, a positive MRI signal radioactive seed location marker designed to improve quality assessment after prostate cancer treatment with brachytherapy, as well as Orion™, an MRI localization device that enables accurate MRI–based pre-treatment planning for all cancer patients being treated with high dose rate (HDR) brachytherapy. Sirius and Orion enable the adoption of MARS – MRI-Assisted RadioSurgery. C4’s multimodality fiducial marker, Nova™, was recently FDA cleared; Nova allows the benefits of positive-signal MRI treatment management to be offered to the hundreds of thousands of patients who receive radiotherapy or proton therapy each year. To learn more, please visit www.c4imaging.com.

About Valley View

Valley View is an independent, not-for-profit health system based in Glenwood Springs, Colorado. Founded in 1955 with funds raised by the community, Valley View Hospital has evolved to serve the healthcare needs of the region. In addition to its 78-bed hospital in Glenwood Springs, Valley View now includes an integrated system of specialty centers and physicians practices providing care in multiple locations across Garfield, Pitkin, Eagle and Mesa counties. Cardiovascular care, including open heart surgery, comprehensive cancer care, neurosurgical and orthopedic care, provide a level of specialty care that enable patients to stay close to home for key healthcare needs. A network of primary care practices support optimal health and the management of patients’ total health. As part of Valley View’s commitment to the community, it hosts health fairs, blood drives, a Kids & Teen Safety Fair and physician-led education series. Valley View has been recognized for performance excellence from Healthgrades, J.D. Power & Associates, Truven Health “Top 100 Hospitals”, Planetree, Survey Vitals and Consumer Reports. PeopleCare. That’s Valley View. www.vvh.org.

For further information:

Andrew Bright

Tel: 609 933 5895

[email protected]

Copyright © 2022

Sirius is a registered trademark of C4 Imaging

Orion and Nova are trademarks of C4 Imaging

Andrew Bright
C4 Imaging
+1 609-933-5895
email us here
Visit us on social media:
Facebook
LinkedIn

You just read:

News Provided By

May 31, 2022, 19:00 GMT


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.



Article originally published on www.einpresswire.com as C4 Imaging Announces First Prostate Cancer Treatments Utilizing Nova™ Fiducial Markers

Business

Post navigation

Previous Post: Global Commercial And Service Industry Machinery Market Size And Market Growth Opportunities
Next Post: BREAKING NEWS: Confirmed England Euro 2020 Squad

Related Posts

  • Moringa Ingredients Market Growth Is Attributed To The Shift In Customer Preference Towards Plant-Based Foods
    Moringa Ingredients Market Growth Is Attributed To The Shift In Customer Preference Towards Plant-Based Foods Business
  • Trump speaks at GOP convention, questions about Dr. Fauci’s email responses, and more
    Trump speaks at GOP convention, questions about Dr. Fauci’s email responses, and more Business
  • UnifyCloud adds landing zone capabilities to its CloudAtlas Platform
    UnifyCloud adds landing zone capabilities to its CloudAtlas Platform Business
  • Day 5 – Evening News – SportAccord Convention 2015
    Day 5 – Evening News – SportAccord Convention 2015 Business
  • ARY News | Prime Time Headlines | 3 PM | 26th May 2022
    ARY News | Prime Time Headlines | 3 PM | 26th May 2022 Business
  • Sunshine Coast Health Centre Announces Supports Post-Addiction Recovery from Drugs, Alcohol, PTSD, and Trauma in Canada
    Sunshine Coast Health Centre Announces Supports Post-Addiction Recovery from Drugs, Alcohol, PTSD, and Trauma in Canada Business
July 2022
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jun    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • 212Quest to Host Travel Quest Adventure in UK & IrelandJuly 6, 2022
  • Mayor Demings Won’t DebateJuly 5, 2022
  • Strategies For Global Cutlery And Hand Tools Market Players In 2022-2026 Market Forecast PeriodJuly 5, 2022
  • Industry Size, CAGR Status, Scope and Challenges to 2028July 5, 2022
  • Journalist Ali Cinar explains the critical results of 2022 Madrid summitJuly 5, 2022
how to promote press release
VUGA Enterprises - media group PR & Marketing
  • World Balloon Convention on Fox 5 News
    World Balloon Convention on Fox 5 News Business
  • Metalworking Fluids Market is Projected to Grow at a CAGR of 3.7% from 2021 to 2031
    Metalworking Fluids Market is Projected to Grow at a CAGR of 3.7% from 2021 to 2031 Business
  • Coldwell Banker Select 2nd Annual Life Jacket Drive
    Coldwell Banker Select 2nd Annual Life Jacket Drive Real Estate
  • CATL Will Supply Cylindrical Battery Cells For Next Gen BMW EVs Aviation
  • Good News for Renewable Energy Stock | best green energy stocks 2022 | wind energy
    Good News for Renewable Energy Stock | best green energy stocks 2022 | wind energy Energy
  • 1st Class Experiences Exponential Growth by Adding on 14 New Franchises in Only One Month
    1st Class Experiences Exponential Growth by Adding on 14 New Franchises in Only One Month Real Estate
  • Æsir Technologies Awarded Phase 2 funding from National Science Foundation for groundbreaking Lithium-Zinc Ion Battery
    Æsir Technologies Awarded Phase 2 funding from National Science Foundation for groundbreaking Lithium-Zinc Ion Battery Energy
  • Australian real estate market shows mixed signs | 7.30
    Australian real estate market shows mixed signs | 7.30 Real Estate
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2022 195News.

| Part of VUGA Media Group | Fair Use | Terms of Use | Get Published